Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Victor Albarran-Artahona"'
Autor:
Laura Mezquita, Leslie A. Bucheit, Juan Carlos Laguna, Belen Pastor, Cristina Teixido, Teresa Gorria, Victor Albarran-Artahona, Marta Garcia de Herreros, Roxana Reyes, Noemi Reguart, Nuria Vinolas, Ainara Arcocha, Joan Anton Puig-Butillé, Leylah Drusbosky, Iris Faull, Elena Castro, Jyoti D. Patel, Aleix Prat, Benjamin Besse
Publikováno v:
Journal of Clinical Oncology. 40:10569-10569
10569 Background: Preliminary data has highlighted inherited predisposition to lung cancer (LC) related to certain pathogenic germline variant (PGV) in cancer predisposing genes, including patients (pts) with tumors harboring somatic driver oncogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f5eca126bbdadddff5003c190825451
https://doi.org/10.1200/jco.2022.40.16_suppl.10569
https://doi.org/10.1200/jco.2022.40.16_suppl.10569
Autor:
Matthew R. Orton, Evan Hann, Simon J. Doran, Scott T. C. Shepherd, Derfel Ap Dafydd, Charlotte E. Spencer, José I. López, Víctor Albarrán-Artahona, Francesca Comito, Hannah Warren, Joshua Shur, Christina Messiou, James Larkin, Samra Turajlic, on behalf of the TRACERx Renal Consortium, Dow-Mu Koh
Publikováno v:
Cancer Imaging, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background The aim of this work is to evaluate the performance of radiomics predictions for a range of molecular, genomic and clinical targets in patients with clear cell renal cell carcinoma (ccRCC) and demonstrate the impact of novel featu
Externí odkaz:
https://doaj.org/article/776e2f4a16584d99afb2c139c1ffe7f5
Autor:
Giannis Mountzios, MD, PhD, David Planchard, MD, PhD, Giulio Metro, MD, PhD, Dora Tsiouda, Arsela Prelaj, MD, Sofia Lampaki, MD, PhD, Walid Shalata, MD, Mariona Riudavets, Petros Christopoulos, MD, PhD, Nicolas Girard, MD, PhD, Víctor Albarrán-Artahona, Rosario Garcia Campelo, MD, PhD, Konstantinos Samitas, MD, PhD, Giuseppe Luigi Banna, MD, Ioannis Boukovinas, MD, PhD, Abed Agbarya, MD, PhD, Anna Koumarianou, MD, Eleni-Isidora Perdikouri, Paris Kosmidis, Helena Linardou, MD, PhD, David Mauri, MD, PhD, Dimitrios Mavroudis, MD, PhD, Ilias Athanasiadis, MD, PhD, Haralambos Kalofonos, Nikolaos Xenidis, MD, PhD, Ippokratis Korantzis, MD, Alexandros Ardavanis, Grigorios Rallis, MD, Achille Bottiglieri, Konstantinos Efthymiadis, MD, Georgios Oikonomopoulos, MD, Alexandros Kokkalis, MD, Emmanouil Saloustros, MD, PhD, Nikolaos Tsoukalas, MD, Dimitra Bartzi, MD, Panagiota Economopoulou, Amanda Psyrri, MD, PhD, Martin Reck, Giuseppe Lo Russo, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100433- (2023)
Introduction: Real-world evidence regarding molecular epidemiology and management patterns of patients with EGFR exon-20 mutated, advanced NSCLC outside the context of clinical trials is lacking. Methods: We created a European registry for patients w
Externí odkaz:
https://doaj.org/article/1da16fe8f3c8428eb04732eb21d2f835
Autor:
Víctor Albarrán-Artahona, Juan-Carlos Laguna, Teresa Gorría, Javier Torres-Jiménez, Mariona Pascal, Laura Mezquita
Publikováno v:
Diagnostics, Vol 12, Iss 9, p 2091 (2022)
Immunotherapy has dramatically changed the therapeutic landscape of oncology, and has become standard of care in multiple cancer types in front or late lines of therapy, with some longstanding responses and outstanding results. Notwithstanding, its u
Externí odkaz:
https://doaj.org/article/d54bdb7b98ff4fa1954355333c7de9d4
Autor:
Lourdes Peña-Jaimes, Irene González-García, María Eugenia Reguero-Callejas, Ignacio Pinilla-Pagnon, Belén Pérez-Mies, Víctor Albarrán-Artahona, Noelia Martínez-Jañez, Juan Manuel Rosa-Rosa, José Palacios
Publikováno v:
Diagnostic Pathology, Vol 13, Iss 1, Pp 1-6 (2018)
Abstract Background Breast carcinoma with osteoclast-like giant cells (OGCs) is infrequent, being most reported cased described as ductal invasive carcinomas. Invasive pleomorphic lobular carcinoma (PLC) is a distinct morphological variant of invasiv
Externí odkaz:
https://doaj.org/article/696c89dabe454b669c9aee139f0bb6f6